SoftBank Corp and Eye-Net Launch Multi-Phase V2X Collision Prevention Trials
Eye-Net Mobile and SoftBank Corp. have launched a multi-phase collaboration in Japan to validate AI-powered V2X collision prediction and prevention technology following successful proof-of-concept trials. The joint initiative will enable real-time location data exchange among road users, tailor solutions to SoftBank’s requirements, and assess potential introduction into new markets.
1. SoftBank Explores Additional $30 Billion Commitment to OpenAI
SoftBank has entered discussions to invest up to $30 billion more in OpenAI, according to multiple sources. This potential infusion would form part of a broader capital‐raising effort that could total as much as $100 billion for the artificial intelligence developer. If completed, SoftBank’s incremental stake would mark a significant expansion of its existing exposure to OpenAI, where its Vision Fund previously participated in back‐to‐back funding rounds in 2023 and 2024. The talks, described as advanced but nonbinding, have been underway since late December and involve senior SoftBank executives evaluating equity and convertible‐note structures. Investors are watching closely: a fresh commitment from SoftBank could influence valuation benchmarks across the AI industry and shape competitive dynamics among deep‐tech venture backers.
2. Eye-Net and SoftBank Advance Strategic V2X Collaboration in Japan
Foresight Autonomous’s subsidiary, Eye-Net Mobile, and SoftBank Corp. have launched a multi-phase plan to validate Eye-Net’s vehicle-to-everything collision-prevention technology on Japanese roads. The joint initiative builds on a proof-of-concept completed in mid-2025 that achieved real-time hazard alerts with 95 percent accuracy in urban driving scenarios. Over the next six months, the partners will integrate Eye-Net’s AI-driven sensor suite with SoftBank’s cellular network infrastructure to exchange positional data among vehicles, cyclists and pedestrians. The project aims to reduce impact-zone incidents by at least 40 percent in trial zones and to map deployment pathways for metropolitan areas housing more than 10 million residents. Success in Japan could pave the way for rollouts across Southeast Asia and Europe by 2027.